Mobile

Clinical trial to investigate cetuximab in combination with capecitabine and cisplatin versus capecitabine and cisplatin alone as first-line treatment for patients with advanced gastric cancer. ...

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-004219-75

Clinical trial to investigate cetuximab in combination with capecitabine and cisplatin versus capecitabine and cisplatin alone as first-line treatment for patients with advanced gastric cancer. Klinikai vizsgálat a capecitabine-nel és cisplatinnal kombinált cetuximab terápia kiértékelésére az önmagában adott capecitabine-nel és cisplatinnal összehasonlítva mint elsővonalbeli terápia előrehaladott gyomorrákban szenvedő betegek körében

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of this study is to demonstrate that addition of cetuximab to 1st-line treatment with XP chemotherapy regimen has a clinically relevant benefit for subjects with advanced gastric adenocarcinoma including GEJ adenocarcinoma, in terms of PFS.

Critère d'inclusion

  • Advanced esophago-gastric cancer

Liens